Republican Endocrinology Center Hospital, Minsk, Republic of Belarus Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2004
NCT00138736
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Alternative names

Deputy Director for Research, Republican Scientific and Practical Center for Mental Health, Minsk, Belarus

Active Ingredients

Drugs in Phase 2 Trials (3)

ard-0403 (1 trial)

autologous mesenchymal cells (1 trial)

mannose binding lectin (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Epilepsy (Phase 2)

Hypogonadism (Phase 2)

Neutropenia (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 3
  • # of Trial APIs: 3